The role of genomics in common variable immunodeficiency disorders

Clinical and Experimental Immunology

Volumn 188, Issue 3, 2017, Pages 326-332

  Kienzler, A K ^a   Hargreaves, C E ^a   Patel, S Y ^a  

^a NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

CVID; genomics; immunodeficiency

Indexed keywords

CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER MODEL; EPIGENETICS; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; MOLECULAR PATHOLOGY; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; REVIEW; GENETIC PREDISPOSITION; GENETICS; PERSONALIZED MEDICINE; PROCEDURES; SEQUENCE ANALYSIS;

COMMON VARIABLE IMMUNODEFICIENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; PRECISION MEDICINE; SEQUENCE ANALYSIS;

EID: 85016593058     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12947     Document Type: Review

References (48)

1. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463–7.
2. Prober J, Trainor GL, Dam RJ et al. A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides. Science 1987; 238:336–41.
3. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431:931–45.
4. Abecasis GR, Auton A, Brooks LD et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491:56–65.
5. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012; 90:7–24.
6. Shendure J, Aiden EL. The expanding scope of DNA sequencing. Nat Biotechnol 2012; 30:1084–94.
7. Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP. Sequencing depth and coverage: key considerations in genomic analyses. Nat Rev Genet 2014; 15:121–32.
8. Hodges E, Xuan Z, Balija V et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 2007; 39:1522–7.
9. Abel HJ, Duncavage EJ. Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches. Cancer Genet 2013; 206:432–40.
10. Masser DR, Stanford DR, Freeman WM. Targeted DNA methylation analysis by next-generation sequencing. J Vis Exp 2015; 96: 52488.
11. Cohen NR, Brennan PJ, Shay T et al. Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol 2013; 14:90–9.
12. Scharer CD, Blalock EL, Barwick BG et al. ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells. Sci Rep 2016; 6:27030.
13. Bousfiha A, Jeddane L, Al-Herz W et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 2015; 35:727–38.
14. Al-Herz W, Bousfiha A, Casanova JL et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011; 2:54.
15. Puck JM, Deschênes SM, Porter JC et al. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 1993; 2:1099–104.
16. Vetrie D, Vořechovský I, Sideras P et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226–33.
17. Villa A, Santagata S, Bozzi F et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998; 93:885–96.
18. Driscoll DA, Salvin J, Sellinger B et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993; 30:813–7.
19. Li F-Y, Chaigne-Delalande B, Kanellopoulou C et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 2011; 475:471–6.
20. Liu L, Okada S, Kong XF et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011; 208:1635–48.
21. Dickinson RE, Griffin H, Bigley V et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 2011; 118:2656–8.
22. Zhang K, Chandrakasan S, Chapman H, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood 2014; 124:1331–4.
23. Orange JS, Glessner JT, Resnick E et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 2011; 127:1360–7.e6.
24. Nijman IJ, van Montfrans JM, Hoogstraat M et al. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol 2014; 133:529–34.
25. Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med 2014; 370:2418–25.
26. Moens LN, Falk-Sörqvist E, Asplund AC, Bernatowska E, Smith CI, Nilsson M. Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLOS ONE 2014; 9:e114901.
27. Sulonen A-M, Ellonen P, Almusa H et al. Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol 2011; 12:R94.
28. Shendure J. Next-generation human genetics. Genome Biol 2011; 12:408.
29. Chapel H, Lucas M, Lee M et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112:277–86.
30. Resnick ES, Cunningham-Rundles C. The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol 2012; 12:595–601.
31. Thiel J, Kimmig L, Salzer U et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012; 129:801–10.e6.
32. Warnatz K, Salzer U, Rizzi M et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA 2009; 106:13945–50.
33. Grimbacher B, Hutloff A, Schlesier M et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4:261–8.
34. van Zelm MC, Smet J, Adams B et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010; 120:1265–74.
35. Kuijpers TW, Bende RJ, Baars PA et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010; 120:214–22.
36. van Zelm MC, Reisli I, van der Burg M et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354:1901–12.
37. Kamin RM, Fudenberg HH, Douglas SD. A genetic defect in ‘acquired’ agammaglobulinemia. Proc Natl Acad Sci USA 1968; 60:881–5.
38. de Bakker PIW, McVean G, Sabeti PC et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38:1166–72.
39. Keller M, Glessner J, Resnick E et al. Burden of copy number variation in common variable immunodeficiency. Clin Exp Immunol 2014; 177:269–71.
40. Li J, Jørgensen SF, Maggadottir SM et al. Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells. Nat Commun 2015; 6:6804.
41. Maggadottir SM, Li J, Glessner JT et al. Rare variants at 16p11.2 are associated with common variable immunodeficiency. J Allergy Clin Immunol 2015; 135:1569–77.
42. Park J, Munagala I, Xu H et al. Interferon signature in the blood in inflammatory common variable immune deficiency. PLOS ONE 2013; 8:e74893.
43. Salzer U, Unger S, Warnatz K. Common variable immunodeficiency (CVID): exploring the multiple dimensions of a heterogeneous disease. Ann NY Acad Sci 2012; 1250:41–9.
44. Rodríguez-Cortez VC, Del Pino-Molina L, Rodríguez-Ubreva J et al. Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during naïve-to-memory B-cell transition. Nat Commun 2015; 6:7335.
45. Lai AY, Mav D, Shah R et al. DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation. Genome Res 2013; 23:2030–41.
46. Lee S-T, Xiao Y, Muench MO et al. A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network. Nucleic Acids Res 2012; 40:11339–51.
47. Kienzler A-K, Rizzi M, Reith M, Nutt SL, Eibel H. Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid. J Allergy Clin Immunol 2013; 131:1695–9.
48. van Schouwenburg PA, Davenport EE, Kienzler AK et al. Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin Immunol 2015; 160:301–14.